Concepedia

R. M. Scarborough

RM

Statistics

Publications

7

Citations

1.3K

H-Index

7

Active since

1991

Affiliations

Rapt Therapeutics (United States)(Current)

R. M. Scarborough is an author at Rapt Therapeutics (United States) specializing in biochemistry, platelet physiology, and ligand binding.

Publications per year

1991–2001

7

Publications

7

Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri

R. M. Scarborough, Jack W. Rose, Mei‐Ling Hsu et al. · Journal of Biological Chemistry · 1991 · 370 citations · Full text

, , +14

Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.

R. M. Scarborough, M.A. Naughton, Willy Teng et al. · Journal of Biological Chemistry · 1992 · 290 citations · Full text

, , +17

Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide

Israel Charo, L Nannizzi, David R. Phillips et al. · Journal of Biological Chemistry · 1991 · 221 citations · Full text

, , +17

Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes.

Rosemary J. Santulli, Claudia K. Derian, Andrew L. Darrow et al. · Proceedings of the National Academy of Sciences · 1995 · 182 citations

, , +11

Endocytosis of fibrinogen into megakaryocyte and platelet alpha- granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa) [published erratum appears in Blood 1993 Nov 1;82(9):2936]

P. J. Handagama, R. M. Scarborough, MA Shuman et al. · Blood · 1993 · 163 citations · Full text

, , +15

1–5 of 7